Research Topics
Species | S KapurSummaryAffiliation: Centre for Addiction and Mental Health Country: Canada Publications
| Collaborators
|
Detail Information
Publications
How antipsychotics work-from receptors to realityShitij Kapur
Centre for Addiction and Mental Health, Toronto, Canada M5S 1A1 University of Toronto, Toronto, Canada
NeuroRx 3:10-21. 2006..The implications of these findings for clinical care, animal models, future target discovery and drug development are discussed...
Atypical antipsychotics: new directions and new challenges in the treatment of schizophreniaS Kapur
Schizophrenia Program, PET Centre, CAMH, Toronto, Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Annu Rev Med 52:503-17. 2001..e. positive, negative, cognitive, and affective) with more selective drugs that can be combined and individually titrated to the needs of each patient...
Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapineS Kapur
PET Centre, Clarke Division, CAMH, Toronto, ONT Canada
Am J Psychiatry 158:311-4. 2001....
Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQS Kapur
Schizophrenia Program, CAMH, Ontario, Toronto, Canada
Neuropsychopharmacology 23:595-8. 2000....
Drug-induced receptor occupancy: substantial differences in measurements made in vivo vs ex vivoS Kapur
Schizophrenia Program and PET Centre, The Clarke Division of the CAMH, Toronto, Ontario, Canada
Psychopharmacology (Berl) 157:168-71. 2001..While these methods are often used interchangeably, there has been no systematic comparison of their sensitivities and consistency...
Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic actionS Kapur
Department of Psychiatry, University of Toronto, Ont
J Psychiatry Neurosci 25:161-6. 2000..The objective of this study was to determine the relationship between kon, koff and the affinity (Ki) of antipsychotic agents for the D2 receptors, with particular reference to typical and atypical antipsychotic agents...
Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancyShitij Kapur
Centre for Addiction and Mental Health, Clarke Site 250 College Street Toronto, Ontario Canada M5R 1T8
J Pharmacol Exp Ther 305:625-31. 2003..The study provides a rationale as well as clinically comparable dosing regimens for animal studies and raises questions about the inferences drawn from previous studies that have used doses unrepresentative of the clinical situation...
The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in ratsS Kapur
Centre for Addiction and Mental Health, Clarke Division, 250 College Street, Toronto, Ontario, Canada M5R 1T8
J Pharmacol Exp Ther 302:1129-34. 2002..1 = 6), olanzapine (0.30/0.43 = 0.7). These results indicate that dissociation between central and peripheral D2 receptor occupancy is a major determinant of the degree of prolactin elevation observed at therapeutic doses...
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesisS Kapur
Schizophrenia Program and the PET Centre of the Centre for Addiction and Mental Health, University of Toronto, Canada
Am J Psychiatry 158:360-9. 2001..This article provides a new hypothesis about the mechanism of action of atypical antipsychotics...
Half a century of antipsychotics and still a central role for dopamine D2 receptorsShitij Kapur
Schizophrenia Program, CAMH, Toronto, ON, Canada
Prog Neuropsychopharmacol Biol Psychiatry 27:1081-90. 2003..g., positive, negative, cognitive, and affective) that can be flexibly used and titrated in the service of patients' presenting psychopathology...
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophreniaShitij Kapur
Clarke Division of the Centre for Addiction and Mental Health, 250 College St, Toronto, Ont M5T 1R8, Canada
Am J Psychiatry 160:13-23. 2003..The objective of this overview is to link the neurobiology (brain), the phenomenological experience (mind), and pharmacological aspects of psychosis-in-schizophrenia into a unitary framework...
NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophreniaS Kapur
Center for Addiction and Mental Health, Clarke Site, Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, Canada M5R 1T8
Mol Psychiatry 7:837-44. 2002..These findings confound the inferences one can draw from the ketamine/PCP models of schizophrenia...
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigationS Kapur
Schizophrenia Division, Clarke Institute of Psychiatry, Toronto, Ont, Canada
Am J Psychiatry 155:921-8. 1998..The purpose of this study was to investigate olanzapine's binding to the serotonin 5-HT2 and dopamine D2 receptors in schizophrenic patients being treated with clinically relevant doses...
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophreniaS Kapur
The Clarke Institute of Psychiatry, Department of Psychiatry, University of Toronto, ON, Canada
Am J Psychiatry 156:286-93. 1999..The purpose of this study was to compare the D2 and serotonin 5-HT2 receptor occupancies of these drugs in patients receiving multiple-dose, steady-state regimens...
PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophreniaS Kapur
Schizophrenia Division, Clarke Institute of Psychiatry, University of Toronto, Canada
Am J Psychiatry 154:1525-9. 1997..The purpose of this study was to document loxapine's 5-HT2 and D2 receptor occupancy in vivo in patients with psychoses...
The D2 receptor occupancy profile of loxapine determined using PETS Kapur
Schizophrenia Division, Clarke Institute of Psychiatry, Toronto, ON, Canada
Neuropsychopharmacology 15:562-6. 1996..This dose range is much lower than that used in most clinical settings and points to the potential efficacy of loxapine at lower doses...
A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancyS Kapur
Department of Psychiatry, University of Toronto, Ontario
Arch Gen Psychiatry 57:553-9. 2000..The following study was undertaken to explore these effects across the clinical dose range and relate this information to its clinical profile...
A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophreniaN P Verhoeff
PET Centre and Schizophrenia and Continuing Care Division, Clarke Site, Centre for Addiction and Mental Health, University of Toronto, ON, M5T 1R8, Toronto, Canada
Psychiatry Res 99:123-35. 2000..Thus, in agreement with the previous ROI studies, voxel-by-voxel analysis confirmed the lack of substantial 5-HT(2A)R BP differences between schizophrenic patients and control subjects...
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET studyS Kapur
PET Centre, Clarke Institute of Psychiatry, Toronto, Ont, Canada
Am J Psychiatry 153:948-50. 1996..The purpose of this study was to determine the dopamine D2 receptor occupancy induced by low-dose haloperidol treatment in a prospective trial...
A new framework for investigating antipsychotic action in humans: lessons from PET imagingS Kapur
Clarke Institute of Psychiatry, Department of Psychiatry, University of Toronto, ON, Canada
Mol Psychiatry 3:135-40. 1998..The justification, limitations and the value of this framework in understanding and investigating newer antipsychotics is discussed...
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PETG Remington
Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Ontario, Canada
J Clin Psychiatry 60:15-9. 1999..Combined serotonin-2/dopamine-2 (5-HT2/D2) antagonism represents one such model, and we now have PET evidence available that can be extrapolated to our understanding and clinical use of both conventional and novel antipsychotics...
A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjectsN P Verhoeff
PET Centre and Schizophrenia and Continuing Care Division, Clarke Site, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
Neuropsychopharmacology 25:213-23. 2001....
Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging studyJ H Meyer
Clarke Institute of Psychiatry, Department of Psychiatry, University of Toronto, Ont, Canada
Am J Psychiatry 156:1029-34. 1999..The objective of this study was to evaluate 5-HT2 receptors in depressed patients who were medication-free and who had not made recent suicide attempts...
Significant dissociation of brain and plasma kinetics with antipsychoticsJohannes Tauscher
Schizophrenia PET program, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
Mol Psychiatry 7:317-21. 2002..Our results question the current reliance on plasma kinetics as the main basis for dosing regimens of antipsychotics. Studies of brain kinetics may provide a sounder basis for determining dosing schedules of psychotropic medications...
Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PETJ Tauscher
PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Neuropsychopharmacology 24:522-30. 2001..Hence, careful age matching may be recommended for future studies using PET and [11C]WAY-100635 to examine 5-HT1A receptors...
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficientS Kapur
Schizophrenia Program, University of Toronto, Toronto, Canada
Biol Psychiatry 50:873-83. 2001....
Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the benchS Kapur
PET Centre, Centre for Addiction and Mental Health, Toronto, ON
Can J Psychiatry 45:241-6. 2000..We exemplify how this dosing confounder could lead to inappropriate conclusions. Data from the bedside translated to the bench--using D2 occupancy as a mediating variable--will lead to more valid animal models...
Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in ratsM G Wadenberg
Centre for Addiction and Mental Health, Toronto, Canada
Biol Psychiatry 47:670-6. 2000..A similar deficit can be produced by dopamine (DA) and by 5-HT(2A/C) receptor agonists in rats. Antipsychotic compounds reverse this effect...
Dopamine D2 receptors internalize in their low-affinity stateF Ko
Department of Pharmacology, Medical Science Building, Room 4344, University of Toronto, Toronto, Ont. M5S 1A8
Neuroreport 13:1017-20. 2002....
Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in ratsM L Wadenberg
Section of Biopsychology, CAMH, University of Toronto, Canada
Psychopharmacology (Berl) 150:422-9. 2000..However, the quantitative relationship between striatal D2 occupancy and effects in these models is not known...
Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancyS Kapur
Clarke Institute of Psychiatry, Center for Addictions and Mental Health, Toronto, Ontario, Canada
Biol Psychiatry 45:1217-20. 1999..A review of pharmacologic and behavioral data suggested that amoxapine should also conform to this profile; therefore, we undertook a positron-emission tomography (PET) study of its 5-HT2 and D2 occupancy...
In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperoneW Sun
PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Mol Pharmacol 63:456-62. 2003....
Dopamine depletion results in increased neostriatal D(2), but not D(1), receptor binding in humansN P L G Verhoeff
Kunin Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada
Mol Psychiatry 7:233, 322-8. 2002..Thus, while DA depletion "uncovers" D(2)receptors, it does not do so for D(1) receptors. The implications of this finding for measuring endogenous DA and its effects on in vivo receptor binding in humans are discussed...
5-HT2 antagonism and EPS benefits: is there a causal connection?S Kapur
PET Centre, Clark Institute of Psychiatry, Toronto, Canada
Psychopharmacology (Berl) 124:35-9. 1996..The implications of these findings for the next generation of combined 5-HT2/D2 antagonists are discussed...
Pharmacotherapy of first-episode schizophreniaG Remington
Department of Psychiatry, University of Toronto, Canada
Br J Psychiatry Suppl 172:66-70. 1998..A growing interest in first-episode schizophrenia reflects the belief that this line of investigation will lead to further developments regarding schizophrenia's aetiology, course and outcome...
Atypical antipsychotics: are some more atypical than others?G Remington
Schizophrenia Program, Centre for Addiction and Mental Health, Clarke Division, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Psychopharmacology (Berl) 148:3-15. 2000..The precise pharmacologic mechanisms underlying "atypicality" remain unclear, but several conceptual frameworks are highlighted that characterize, and perhaps differentiate, these newer agents...
The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging studyJ H Meyer
Clarke Division, Centre for Addictions and Mental Health, Department ofPsychiatry, University of Toronto, Ontario, Canada
Am J Psychiatry 158:78-85. 2001..The objective of this study was to evaluate the effect of 6 weeks of paroxetine treatment on 5-HT(2A) receptors in depressed patients...
The amphetamine-induced sensitized state as a model of schizophreniaR E Featherstone
Section of Biopsychology, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Prog Neuropsychopharmacol Biol Psychiatry 31:1556-71. 2007..It is concluded that amphetamine sensitization likely impacts behaviour by altering the functioning of mesolimbic dopamine systems and prefrontal cortical function and can serve as a model of certain domains of schizophrenia...
Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]H2O PET study in humansJ H Meyer
Clarke Institute of Psychiatry, Department of Psychiatry, University of Toronto, Ontario, Canada
Neurosci Lett 207:25-8. 1996..These results support further investigation with intravenous d-fenfluramine to study the net functional effects of serotonergic stimulation in health and illness...
SB-277011 GlaxoSmithKlineG Remington
Center for Addiction and Mental Health, Toronto, Ontario, Canada
Curr Opin Investig Drugs 2:946-9. 2001....
The effects of divided attention on encoding- and retrieval-related brain activity: A PET study of younger and older adultsN D Anderson
University of Toronto and Rotman Research Institute, Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada
J Cogn Neurosci 12:775-92. 2000....
Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studiesJ Tauscher
Schizophrenia PET program, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
CNS Drugs 15:671-8. 2001..This seems to be particularly important in individuals experiencing a first episode of schizophrenia, as they appear to be especially responsive to pharmacotherapy and quite sensitive to adverse effects...
Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effectsM L Wadenberg
Schizophrenia Program, PET Center, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario M5T 1R8, Canada
Neuropsychopharmacology 25:633-41. 2001..The implications of this finding for understanding antipsychotic action as well as the continued use of these models in drug discovery is discussed...
Cerebral gray matter volume deficits in first episode psychosisR B Zipursky
Clarke Institute of Psychiatry, Department of Psychiatry, University of Toronto School of Medicine, Ontario, Canada
Arch Gen Psychiatry 55:540-6. 1998..We hypothesized that deficits in gray matter volume would be present in patients presenting with a first episode of nonaffective psychosis...
A positron emission tomography study of silent and oral single word reading in stuttering and nonstuttering adultsL F De Nil
Department of Speech Language Pathology, University of Toronto, The Toronto Western Hospital, Ontario, Canada
J Speech Lang Hear Res 43:1038-53. 2000..The results of the present study provide qualified support for the hypothesis that stuttering adults show atypical lateralization of language processes...
Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosisD S Sa
Movement Disorders Unit, Division of Neurology, Toronto Western Hospital, ON, Canada
Clin Neuropharmacol 24:242-4. 2001..Therefore, although we found some support for amoxapine having antipsychotic properties, this drug seems to carry a risk of worsening motor function in patients with PD...
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophreniaOfer Agid
Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, ON, Canada
Neuropsychopharmacology 32:1209-15. 2007....
Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studiesSridhar Natesan
1Schizophrenia Program and the PET Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada
Neuropsychopharmacology 32:1540-9. 2007....
In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive systemLaurent Galineau
The Vivian Rakoff Positron Emission Tomography Unit, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Synapse 60:172-83. 2006..These results substantiate the use of [11C]-(+)-PHNO as an agonist radiotracer for D2-imaging. The sensitivity of its binding to competition with endogenous DA suggests an association with the subset of high affinity state D2-receptors...
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal modelsSridhar Natesan
Schizophrenia Program and the PET Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada
Neuropsychopharmacology 31:1854-63. 2006..Partial agonism of aripiprazole offers a good explanation for this dissociation and provides a framework for understanding occupancy-functional relationships of partial D2 agonist antipsychotics...
Linking animal models of psychosis to computational models of dopamine functionAndrew J Smith
Bentley Heath, Solihull, West Midlands, UK
Neuropsychopharmacology 32:54-66. 2007..The model's primary contribution is to link dopamine neuron firing, receptor manipulation, and behavior within a common formal framework that may offer insights into clinical observations...
The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor sidSridhar Natesan
Schizophrenia Program and PET Centre, Toronto, Ontario, Canada
J Pharmacol Exp Ther 318:810-8. 2006..The results suggest that dopamine stabilizers exhibit locomotor stabilizing as well as antipsychotic-like effects, with low motor side effect liability, in a dose range that corresponds to high D2 in vivo occupancy...
Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomographyNathalie Ginovart
The Vivian Rakoff Positron Emission Tomography Unit, Center for Addiction and Mental Health, Toronto, Canada
J Neurochem 97:1089-103. 2006....
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidoneGary Remington
Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ont M5T 1R8, Canada
Am J Psychiatry 163:396-401. 2006..The present study used positron emission tomography (PET) to evaluate its dopamine D(2) binding profile at doses of 25, 50, or 75 mg administered every 2 weeks...
Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosisRobert B Zipursky
Department of Psychiatry, University of Toronto, Ontario
Can J Psychiatry 50:462-9. 2005..We undertook this study to determine whether response to the atypical antipsychotic olanzapine occurs at lower levels of D2 receptor occupancy...
Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNOPhilip Seeman
Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
Synapse 61:263-7. 2007..2-3.5-fold increase of DA D2(High) receptors may explain why amphetamine-sensitized animals are much more sensitive to DA agonists, even though the total density of D2 receptors may apparently be unchanged or even decreased...
Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophreniaHiroyuki Uchida
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
J Clin Psychiatry 69:1281-6. 2008..The objective of this positron emission tomography (PET) study was to examine the striatal dopamine D(2) binding of long-acting risperidone administered intramuscularly once a month...
Quetiapine extended-release versus immediate-release formulation: a positron emission tomography studyDavid C Mamo
Centre for Addiction and Mental Health, PET Centre, Toronto, Ontario, Canada
J Clin Psychiatry 69:81-6. 2008..An extended-release (XR) formulation of quetiapine is currently being developed to achieve similar efficacy using a once-daily dosing regimen. We compared the central D(2) receptor binding between the IR and XR formulations...
Less is more: antipsychotic drug effects are greater with transient rather than continuous deliveryAnne Noël Samaha
Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Biol Psychiatry 64:145-52. 2008..Based on prior data, we predicted that variations in the within-day kinetics of antipsychotic drug delivery would produce different outcomes, even if we held achieved dose, route, and total duration of treatment constant...
'Jumping to conclusions' and delusions in psychosis: relationship and response to treatmentMahesh Menon
Schizophrenia Program and PET Centre, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Canada
Schizophr Res 98:225-31. 2008..The findings suggest that JTC might moderate the effects of treatment on symptomatology, but it does not mediate the treatment induced reduction in delusional intensity...
Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET studyDavid Mamo
Department of Psychiatry, University of Toronto, Toronto, Canada
Am J Psychiatry 164:1411-7. 2007..The authors conducted a positron emission tomography (PET) study to characterize the simultaneous effects of aripiprazole at the D(2), 5-HT(2), and 5-HT(1A) receptors in patients with schizophrenia or schizoaffective disorder...
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humansAriel Graff-Guerrero
PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Hum Brain Mapp 29:400-10. 2008..This differential binding of agonist vs. antagonist radioligand, especially in the critically important region of the limbic striatum/pallidum, offers new avenues to investigate the role of the dopamine system in health and disease...
D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophreniaDavid Mamo
Center for Addiction and Mental Health, Toronto, ON, Canada
Neuropsychopharmacology 33:298-304. 2008..However, supplemental oral olanzapine or another dosing strategy may be necessary to maintain adequate therapeutic response during the first few injection cycles...
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophreniaRomina Mizrahi
Centre for Addiction and Mental Health, Toronto, Ontario, Canada M5S 2S1
Am J Psychiatry 164:630-7. 2007..The authors present the first double-blind controlled study to examine the relationship between striatal and extrastriatal dopamine D(2) receptor binding potential and occupancy values and adverse subjective experience...
"Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over timeAnne Noël Samaha
Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada M5T 1R8
J Neurosci 27:2979-86. 2007..These findings provide a model and a mechanism for antipsychotic treatment failure and suggest new directions for the development of more effective antipsychotics...
From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosisShitij Kapur
Centre for Addiction and Mental Health, Toronto, Canada
Schizophr Res 79:59-68. 2005..The article discusses the caveats, limitations as well as the clinical implications of the salience framework...
Evidence for onset of antipsychotic effects within the first 24 hours of treatmentShitij Kapur
Centre for Addiction and Mental Health, 250 College St, Toronto, Ont, Canada M5R 1T8
Am J Psychiatry 162:939-46. 2005..Recent research has shown that antipsychotic action begins within the first week. The authors tested the hypothesis that psychosis improves within the first 24 hours of antipsychotic treatment...
Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockadeSitra Tauscher-Wisniewski
Schizophrenia and Continuing Care Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Canada
J Clin Psychiatry 63:992-7. 2002..Future studies aimed at evaluating the relative merits of "transiently high" versus "continuously high" D(2) occupancy are warranted...
Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophreniaCatherine C Tenn
Schizophrenia/PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Schizophr Res 64:103-14. 2003....
The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in ratsPeter Turrone
Centre for Addiction and Mental Health, Schizophrenia and Continuing Care Program, 250 College Street, Room 745, Toronto, Ontario, Canada M5T 1R8
Psychopharmacology (Berl) 165:166-71. 2003..A dose-response relationship between dopamine D(2) occupancy and acute extrapyramidal symptoms (EPS) has been well established. However, the link with the induction of tardive dyskinesia (TD) is less clear...
Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6-[18F]-L-m-tyrosineDavid Mamo
Department of Psychiatry, University of Toronto, Canada
Synapse 52:153-62. 2004..Our results suggest that 6-[18F]-L-m-tyrosine PET may not be a useful tool in the study of the effect of antipsychotics on dopamine synthesis in human subjects...
Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challengesPhilip Seeman
Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada M5S 1A8
Synapse 46:235-9. 2002....
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidoneDavid Mamo
Department of Psychiatry, University of Toronto, Montreal, Canada
Am J Psychiatry 161:818-25. 2004....
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychoticsJohannes Tauscher
University of Toronto Department of Psychiatry, Schizophrenia Program
Am J Psychiatry 161:1620-5. 2004....
Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in ratsPeter Turrone
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
Biol Psychiatry 57:406-11. 2005....
Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomographyAlan A Wilson
PET Centre, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Ontario, Canada
J Med Chem 48:4153-60. 2005....
A putative animal model of the "prodromal" state of schizophreniaCatherine C Tenn
Schizophrenia/PET Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto Canada
Biol Psychiatry 57:586-93. 2005..Early intervention, instituted once the prodromal state was already developed, prevented further progression into the full phenotype analogous to schizophrenia...
Contrasting loxapine to its isomer isoloxapine--the critical role of in vivo D2 blockade in determining atypicalitySridhar Natesan
Schizophrenia PET program, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada, M5T 1R8
Schizophr Res 77:189-99. 2005..The purpose of this study was to systematically compare the two drugs in in vitro and in vivo animal models, and to understand mechanisms underlying their differential typical/atypical profiles...
Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic actionShitij Kapur
Department of Psychiatry, University of Toronto, Toronto M5S 3H6, Canada
Neuroreport 13:831-5. 2002..The implications for the design of future antipsychotics is discussed...
Elevation of prolactin levels by atypical antipsychoticsPeter Turrone
Department of Psychiatry, University of Toronto, Ont, Canada
Am J Psychiatry 159:133-5. 2002..Atypical antipsychotics are thought not to elevate prolactin levels. The authors examined data suggesting that atypical antipsychotics do elevate prolactin levels but more transiently than typical antipsychotics...
Clozapine can induce high dopamine D(2) receptor occupancy in vivoTetsuya Suhara
Brain Imaging Project, National Institute of Radiological Sciences, Chiba, Japan
Psychopharmacology (Berl) 160:107-12. 2002..Furthermore, even at maximum occupancy, 70% is not exceeded. Several mechanisms have been proposed as explanations for this low D(2) receptor occupancy, but clear evidence is limited...
Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivoPatrick N McCormick
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada M5S 1A8
Nucl Med Biol 35:11-7. 2008....
The formation of abnormal associations in schizophrenia: neural and behavioral evidenceJimmy Jensen
Schizophrenia Program and the PET Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada
Neuropsychopharmacology 33:473-9. 2008..The aberrant activations and response are consistent with the idea that patients aberrantly assign motivational salience to neutral stimuli, and this process may be one of the aberrations that predisposes them to psychosis...
Early use of clozapine for poorly responding first-episode psychosisOfer Agid
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
J Clin Psychopharmacol 27:369-73. 2007....
Amoxapine shows atypical antipsychotic effects in patients with schizophrenia: results from a prospective open-label studyRogelio Apiquian
Carracci Medical Group, Mexico City, Mexico
Schizophr Res 59:35-9. 2003..To examine if this leads to an atypical antipsychotic effect in the clinical context, the authors examined the antipsychotic and side-effect profile of amoxapine in acutely psychotic patients with schizophrenia...
Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635Johannes Tauscher
PET Centre, Toronto, Ontario
Arch Gen Psychiatry 59:514-20. 2002....
Amoxapine as an antipsychotic: comparative study versus haloperidolImran B Chaudhry
University of Manchester, Manchester, UK
J Clin Psychopharmacol 27:575-81. 2007..However, it did not prove to have fewer extrapyramidal side effects than haloperidol, possibly because the baseline scores were very low...
Amoxapine as an atypical antipsychotic: a comparative study vs risperidoneRogelio Apiquian
Department of Psychiatry, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Av Insurgentes Sur 3877, Mexico City, 14296 Mexico
Neuropsychopharmacology 30:2236-44. 2005..Since amoxapine is off-patent, it may be a valuable low-cost alternative to new atypical antipsychotics, particularly in low-income countries where the majority of the patients are still treated with typical antipsychotics...
First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography studyMatthaus Willeit
Positron Emission Tomography Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
Neuropsychopharmacology 33:279-89. 2008..11)C]-(+)-PHNO PET might be a superior measure for release of endogenous dopamine than PET employing conventional D(2/3) antagonist radioligands...
Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptorsPhilip Seeman
Department of Pharmacology, University of Toronto, Toronto, Ontario M5S JA8, Canada
Synapse 50:35-40. 2003....
Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortexPaul J Fletcher
Section of Biopsychology, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada
Psychopharmacology (Berl) 183:190-200. 2005..These results further add to a growing literature showing that activating D(1) receptors in the mPFC improves aspects of cognition...
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulationZafiris J Daskalakis
Schizophrenia and Continuing Care Program, Centre for Addiction and Mental Health, Department of Psychiatry, Toronto Western General Hospital, University of Toronto, Ontario, Canada
Arch Gen Psychiatry 59:347-54. 2002....
Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibitionCatherine C Tenn
Schizophrenia/PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Psychopharmacology (Berl) 180:366-76. 2005....
Dopamine, prediction error and associative learning: a model-based accountAndrew Smith
Department of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, Ontario, Canada
Network 17:61-84. 2006..The model distinguishes itself from existing accounts by offering novel predictions pertaining to the firing of dopamine neurons in various untested behavioral scenarios...
How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosisShitij Kapur
Centre for Addiction and Mental Health, and the University of Toronto, 33 Russell Street Toronto, Ontario M5S 2S1, Canada
Trends Pharmacol Sci 25:402-6. 2004..The implications of this framework for relapse and other clinical phenomena, animal models and future studies are discussed...
A model of anticholinergic activity of atypical antipsychotic medicationsMarci L Chew
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA
Schizophr Res 88:63-72. 2006..CONCLUSIONS: Therapeutic doses of clozapine, olanzapine, and, to a lesser extent, quetiapine are associated with clinically relevant AA...
The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disordersRomina Mizrahi
CAMH, and Department of Psychiatry, Faculty of Medicine, University of Toronto, Ontario, Canada
Schizophr Res 88:111-8. 2006....
Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophreniaRobert E Featherstone
Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada
Neuropsychopharmacology 32:483-92. 2007..These results support the notion that MAM treatment may simulate some aspects of schizophrenic cognition...
A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortexPaul J Fletcher
Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada
Neuropsychopharmacology 32:1122-32. 2007..The reversal of these deficits by a D1 receptor agonist provides further evidence that prefrontal D1 dopamine receptors are involved in cognition, and may be a potential target for treatment of impaired cognition in schizophrenia...
The effect of antipsychotic treatment on Theory of MindRomina Mizrahi
Centre for Addiction and Mental Health, and Department of Psychiatry, Faculty of Medicine, University of Toronto, Ontario, Canada
Psychol Med 37:595-601. 2007..However, it remains unclear whether TOM deficits constitute a trait- or a state-related deficit and whether they respond to antipsychotic treatment, and also whether the change in TOM and change in psychosis are associated...
A model of antipsychotic action in conditioned avoidance: a computational approachAndrew Smith
Psychology Department, McMaster University, Hamilton, Ontario, Canada
Neuropsychopharmacology 29:1040-9. 2004..The APD action in this model is most consistent with an effect on 'expected future reward'--an idea closely linked to motivational drives and consistent with several leading theories of dopamine action...
